Complex ventricular arrhythmias associated with the mitral valve prolapse syndrome. Effectiveness of moricizine (ethmozine) in patients resistant to conventional antiarrhythmics

Pratt, Craig M.; Young, James B.; Wierman, Ann; Borland, R.Michael; Seals, A. Allen; León, Carlos; Raizner, Albert E.; Quiñones, Miguel Á.; Roberts, Robert

doi:10.1016/0002-9343(86)90818-1

Cited by 13 publications

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although limited by its design and small sample size, this study demonstrates the nonuniformity in response to a beta-blocker in treating symptomatic participants with MVP. In a similar design, 17 participants (12 women, 5 men; mean age = 48) with MVP who were referred to a research clinic because of drug-resistant ventricular arrhythmias were treated with moricizine (Ethmozine) (Pratt et al, 1986). These 17 participants with MVP were a subset of 215 patients referred for treatment.…”

Section: Mvps and Medication Usementioning

confidence: 99%

Medication Use and Symptoms in Individuals With Mitral Valve Prolapse Syndrome

Scordo

2007

Clin Nurs Res

View full text Add to dashboard Cite

Mitral valve prolapse (MVP) is a common valvular heart disease associated with a variety of frightening symptoms. Beta-adrenergic blockers along with calcium channel blockers and anxiolytics are widely used to treat symptoms associated with MVPS despite a lack of evidence that supports their efficacy. This study examined the relationship between prescribed medication use and frequency and intensity of MVPS symptoms. A descriptive cross-sectional survey design was used. Descriptive statistics and Cramér's V correlational analysis were used to answer the research questions. Self-completed questionnaires were mailed to 2,282 MVPS individuals older than 21 years of age throughout the United States and Canada previously diagnosed with MVPS. Of the 837 participants, 337 (40%) were taking one or more medications. Although there were significant positive correlations between anxiety and calcium channel blockers, chest pain and digoxin, and mood swings and digoxin, the correlations were very weak.

show abstract

Section: Mvps and Medication Usementioning

confidence: 99%